Effectiveness of triamcinolone Acetonide Injection for the treatment of Non-infectious Intermediate and Posterior Uveitis
Keywords:
Triamcinolone Injection,, Posterior Sub-Tenon's Injection, Non-Infectious, Intermediate Uveitis, Posterior Uveitis, intraocular pressureAbstract
OBJECTIVE: To assess the efficacy of posterior sub-tenon injection (PSTI) of Triamcinolone Acetonide (TA) in patients with Uveitis.
METHODS: This prospective study was conducted from July 2022 to May 2023. A total of 160 eyes were comprehensively examined at the Kulsoom Bai Valika Social Security Site Hospital and Sindh Government Qatar Hospital. Purposive sampling was employed for participant selection, focusing on the eye with poor vision in patients with Uveitis in both eyes. The sample was stratified into non-infectious posterior Uveitis and non-infectious intermediate Uveitis, maintaining a 1:1 ratio. Statistical analysis was performed using SPSS (version 25.0).
RESULTS: The median duration of Uveitis was 20.5 weeks (interquartile range, IQR: 17-25). The median best-corrected visual acuity before treatment was 0.5 (IQR: 0.4-0.7). After one week, it improved to 0.2 (IQR: 0.1-0.3), and after three months, it further increased to 0.12 (IQR: 0.1-0.18), showing a statistically significant difference (p-value < 0.01) between baseline and one week after treatment. The difference between one week and after 12 weeks remained consistent. Two-way analysis also revealed a significant difference (p-value < 0.01).
CONCLUSION: Posterior sub-tenon injection of triamcinolone acetonide is effective and safe for treating non-infectious Uveitis. The intraocular pressure did not show an increase following the injection, and visual acuity significantly improved after PSTI.
References
Price KW, Albini TA, Yeh S. Suprachoroidal Injection of Triamcinolone—Review of a Novel Treatment for Macular Edema Caused by Non-infectious Uveitis. US Ophthalmic Rev. 2020; 13(2): 76-79. doi: 10.17925/usor.2020.13.2.76.
Maruyama K. Current standardized therapeutic approach for Uveitis in Japan. Immunol Med. 2019; 42(3): 124-34. doi: 10.1080/25785826.2019.1678961. Epub 2019 Oct 24.
Al-Essa RS, Alfawaz AM. New insights into cataract surgery in patients with Uveitis: A detailed review of the current literature. Saudi J Ophthalmol. 2022; 36(2): 133-141. doi: 10.4103/sjopt_sjopt_147_21.
Chen RI, Purgert R, Eisengart J. Gonioscopy-assisted transluminal trabeculotomy and goniotomy, with or without concomitant cataract extraction, in steroid-induced and uveitic glaucoma: 24-month outcomes. J Glaucoma. 2023; 32(6): 501-10.
Pokkalath AS, Sawant A, Sawarkar SP. Herbal medicine for ocular diseases: An age old therapy and its future perspective. J Drug Delivery Sci Technol. 2022; 68: 102979.
Qi Q, Wei Y, Zhang X, Guan J, Mao S. Challenges and strategies for ocular posterior diseases therapy via non-invasive advanced drug delivery. J Control Rel. 2023; 361: 191-211.
Patel D, Patel SN, Chaudhary V, Garg SJ. Complications of intravitreal injections: 2022. Curr Opinion Ophthalmol. 2022; 33(3): 137-46.
Fung AT, Tran T, Lim LL, Samarawickrama C, Arnold J, Gillies M et al. Local delivery of corticosteroids in clinical ophthalmology: A review. Clin Exp Ophthalmol. 2020; 48(3): 366-401.
Agban Y, Thakur SS, Mugisho OO, Rupenthal ID. Depot formulations to sustain periocular drug delivery to the posterior eye segment. Drug Discover Today. 2019; 24(8): 1458-69.
Oncul H, Kara C, Ozdal PC. Evaluation of infectious Uveitis at a tertiary referral center in Turkey: A 31-year retrospective study. Beyoglu Eye J. 2021; 6(2): 115-23.
Baidya K, Roy B, Jain S. Intermediate uveitis: A rare diagnosis of brucellosis in eastern India. Indian J Ophthalmol Case Rept. 2021; 1(3): 524-5.
Accorinti M, Okada AA, Smith JR, Gilardi M. Epidemiology of macular edema in Uveitis. Ocular Immunol Inflam. 2019; 27(2): 169-80.
Standardization of Uveitis Nomenclature for Reporting Clinical Data. Results of the First International Workshop. Am J Ophthalmol. 2005; 140(3): 509-16.
Hogan MJ, Kimura SJ, Thygeson P. Signs and Symptoms of Uveitis*: I. Anterior Uveitis. Am J Ophthalmol. 1959; 47(5 Pt 2): 155-70.
Gull A, Niazi FAK, Raza A. Intravitrealversus Posterior Subtenon Triamcinolone Acetonide in Conjunction with Intravitreal Bevacizumab for Refractory Diabetic Macular Edema. Pak J Ophthalmol. 2022; 38(3). doi: 10.36351/pjo.v38i3.1400.
Erdogan G, Gumus G, Gunay BO, Ozkaya A. Posterior sub-Tenon triamcinolone injection in the treatment of postoperative cystoid macular edema secondary to pars plana vitrectomy. Indian J Ophthalmol. 2023; 71(1): 174-179. doi: 10.4103/ijo_IJO_621_22.
Elkhodary NMM, Hasan ZS, El-Din Mohamed NS. Comparison of Anti-inflammatory Effect between Intracameral Triamcinolone Acetonide and Topical Dexamethasone after Phacoemulsification. Egypt J Hospital Med. 2023; 90(1): 601-6.
Philip SS, Braganza AD, Rebekah GJ. Comparison of a single intraoperative posterior sub-Tenon's capsule triamcinolone acetonide injection versus topical steroids for treatment of postcataract surgery inflammation in children. Oman J Ophthalmol. 2019; 12(1): 25-30. doi: 10. 10.4103/ijo_IJO_147_2017.
Kurup SK, Tabbaa T, Echegaray JJ, Oliver AL. Intraocular inflammation secondary to intravitreal brolucizumab treated successfully with Sub-Tenon triamcinolone: a case report. Am J Ophthalmol Case Rept. 2022; 25: 101289.
Rujkorakarn P, Zhou A, Babiker F, Chang PY. Suprachoroidal Triamcinolone Injection in Posterior Scleritis: A Case Report. Ocul Immunol Inflam. 2023: 1-4.
Ren Y, Du S, Zheng D, Shi Y, Pan L, Yan H. Intraoperative intravitreal triamcinolone acetonide injection for prevention of postoperative inflammation and complications after phacoemulsification in patients with uveitic cataract. BMC Ophthalmol. 2021; 21(1): 1-10.
Ahmed NN, Zamir Q, Ijaz U, Shahid M, Iqbal S. Gender bias in uveitis: results from a study at armed forces institute of ophthalmology rawalpindi. Pak Armed Forces Med J. 2020; 70(Suppl-1): S182-87.
Kikuchi R, Kawagoe T, Hotta K. Vogt–Koyanagi–Harada disease-like Uveitis following nivolumab administration treated with steroid pulse therapy: a case report. BMC Ophthalmol. 2020; 20(1): 1-6.
Holz FG, Lida T, maruko I, Sadda SR. A consensus on risk mitigation for brolucizumab in neovascular age-related macular degeneration. Retina. 2022; 42: 1629-37.
Cankurtaran M, Gediz B?. Sub-Tenon Triamcinolone Acetonide Injection in the Acute Treatment of Handheld Laser-Induced Maculopathy. Turkish J Ophthalmol. 2022; 52(4): 281.
Andjelic G, Jovanovic S, Pesic S, Mitrasevic M, Stojanovic J, Radotic F et al. The efficacy of a posterior sub-tenon's capsule triamcinolone injection in patients with non-infectious intermediate Uveitis and posterior Uveitis. De Gruyter. 2017; 18(2): 151-6.
McKay KM, Borkar DS, Sevgi DD, Susarla G, Papaliodis GN, Sobrin L. Comparison of modified posterior sub-tenon's vs. trans-septal triamcinolone injection for non-infectious Uveitis. Ocul Immunol Inflam. 2021; 29(5): 857-64.
Lin D, Hu J, Wu K, Feng K, Zhao X, Lu Q et al. Synergistic Effect of Combined Sub-Tenon Triamcinolone and Intravitreal Anti-VEGF Therapy for Uveitic Macular Edema. Drug Design Develop Ther. 2022: 1055-66.
Helm CJ, Holland GNJ. The effects of posterior subtenon injection of triamcinolone acetonide in patients with intermediate Uveitis. Am J Ophthalmol. 1995; 120(1): 55-64. doi: 10.1016/s0002-9394(14)73759-6.
Shome A, Mugisho OO, Niederer RL, Rupenthal ID. Blocking the inflammasome: A novel approach to treat Uveitis. Drug Discover Today. 2021; 26(12): 2839-57.
Androudi S, Kaufman AR, Kouvalakis A, Mitsios A, Sapounas S, Al-Khatib D et al. Non-Healing Corneal Ulcer and Uveitis Following Monkeypox Disease: Diagnostic and Therapeutic Challenges. Ocul Immunol Inflamm. 2024: 32(3): 253-258. doi: 10.1080/09273948.2023.2202746. Epub 2023 May 4.
Jung JL, Harasawa M, Patnaik JL, Palestine AG. Subtenon triamcinolone acetonide injection with topical anesthesia in pediatric non-infectious Uveitis. Ophthalmol Ther. 2022; 11(2): 811-20.
Sreelatha PP, Acharya PK, Venugopal KC, Sivakiran R. A clinical study on the efficacy of posterior subtenon injection of triamcinolone acetonide in patients with post fever retinitis. Kerala J Ophthalmol. 2020; 32(2): 148-53.
Sultan S, Shakeel A, Waris N, Bano SJ. Early Visual Recovery in Patients with Diabetic Macular Edema After Giving Intra-vitreal Injection Avastin and Posterior Subtenon Triamcinolone. Ann King Edward Med Univ. 2021; 27(2): 217-222.
Yang Y-H, Hsu W-C, Hsieh Y-T. Anterior Migration of Triamcinolone Acetonide after Posterior Subtenon Injection for Macular Edema Predisposes to Intraocular Pressure Elevation. Curr Eye Res. 2021; 46(5): 689-93.
Yalcinsoy KO, Ozdal PC, Sen E, Elgin U. Intraocular Pressure Elevation After Posterior Subtenon Triamcinolone Acetonide Injection in Pediatric Non-Infectious Uveitis. Beyoglu Eye J. 2022; 7(4): 298-303.
Maeda Y, Ishikawa H, Nishikawa H, Shimizu M, Kinoshita T, Ogihara R et al. Intraocular pressure elevation after subtenon triamcinolone acetonide injection; Multicentre retrospective cohort study in Japan. PloS One. 2019; 14(12): e0226118.
Mundinamani S AP, Venugopal KC. Shruthi K, Parvathy PS. Posterior Subtenon Injection of Triamcinolone (PSTT) for Macular Edema in Various Retinal Conditions. Int J Ophthalmol Eye Res. 2020; 16; 8(3): 429-33.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Journal of Liaquat University of Medical & Health Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Submission of a manuscript to the journal implies that all authors have read and agreed to the content of the undertaking form or the Terms and Conditions.
When an article is accepted for publication, the author(s) retain the copyright and are required to grant the publisher the right of first publication and other non-exclusive publishing rights to JLUMHS.
Articles published in the Journal of Liaquat University of Medical & health sciences are open access articles under a Creative Commons Attribution-Noncommercial - Share Alike 4.0 License. This license permits use, distribution and reproduction in any medium; provided the original work is properly cited and initial publication in this journal. This is in accordance with the BOAI definition of open access. In addition to that users are allowed to remix, tweak and build upon the work non-commercially as long as appropriate credit is given and the new creations are licensed under the identical terms. Or, in certain cases it can be stated that all articles and content there in are published under creative commons license unless stated otherwise.
